Both in Pharmaceuticals
Organogenesis Holdings vs Unicycive Therapeutics
Over the past year ORGO returned −77.6% and UNCY returned −15.5%; their daily moves had a correlation of 0.09.
ORGO −77.6% UNCY −15.5%Growth of $1, one year, split-adjusted
| Metric | ORGO | UNCY |
|---|---|---|
| Price | $0.8700 | $3.75 |
| Market cap | $111.9M | $104.5M |
| Today | +4.19% | +4.46% |
| 1 month | −35.1% | −11.3% |
| 6 months | −66.0% | −53.9% |
| Year to date | −83.2% | −35.0% |
| 1 year | −78.3% | −15.5% |
| Revenue growth (YoY) | −56.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −227.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | — |
| Net cash | $34.4M | $61.4M |
| Dividend yield | — | — |
| Volatility (60d) | 61.2% | 56.7% |
| Short % of float | 21.7% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).